ProRx LLC recalls Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Je
Recalled November 5, 2025 · FDA recall D-0117-2026 · ProRx
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
11,119 vials
Sold at
TX and UT
Description
Lack of Assurance of Sterility
Product
Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09
Manufacturer(s)
ProRx LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →